BIOS Capital Management, LP
CIK: 0001813845Latest portfolio: $82.6M · Q4 2025
Holdings
6
Total Value
$82.6M
New Positions
1
Closed Positions
1
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ACTUACTUATE THERAPEUTICS INC | 10,049,996 | $61.5M | 74.44% | — | |
| 2 | CGTXCOGNITION THERAPEUTICS INC | 6,000,000 | $8.1M | 9.80% | — | |
| 3 | IRDOPUS GENETICS INC | 3,683,429 | $7.4M | 8.96% | — | |
| 4 | LTRNLANTERN PHARMA INC | 1,009,507 | $3.1M | 3.70% | -6,208 | |
| 5 | RNTXREIN THERAPEUTICS INC | 1,690,751 | $2.0M | 2.37% | — | |
| 6 | INABIN8BIO INC | 253,417 | $592K | 0.72% | NEW |
Quarterly Changes
Increased Positions
No increased positions
Decreased Positions
| Name | Shares | Change |
|---|---|---|
| LTRN | 1.0M | -6208 |
Sector Breakdown
Healthcare100.0% ($615058099740330.6T)
Filing History
Fund Information
BIOS Capital Management, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $82.6M across 6 holdings. The largest position is ACTUATE THERAPEUTICS INC (ACTU), representing 74.4% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.